Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Novasep Appoints CFO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Novasep Appoints CFO

Thiry brings 30 years of experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Christian Thiry has been appointed chief financial officer at Novasep. Mr. Thiry has 30 years of audit and finance executive management experience in the life sciences. For the past 12 years he served as chief financial officer and group executive committee member of Stallergenes, a biopharma company, where he helped expand the business, grow market capitalization, and increase profits.
 
“I am delighted to welcome Christian to Novasep’s executive team. This is a key appointment for Novasep as we continue to strengthen our core team which will be critical to driving our future growth,” said Michel Spagnol, chief executive officer, Novasep. “Christian’s broad experience is a major addition to the management team”. We would also like to thank Helen Lee Bouygues for her work as interim CFO to date and her continued support of the company during transition.”
 
Novasep has recently made investments in Mourenx, France, to build a large chromatography plant dedicated to the pharmaceutical industry; in Le Mans, France, to expand manufacturing capabilities of anti-cancer therapies; and in Shanghai, China, to better serve clients in Asia.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters